Jennifer L. Guerriero
Brigham and Women's Hospital(US)Harvard University(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Immune cells in cancer, Monoclonal and Polyclonal Antibodies Research, PARP inhibition in cancer therapy
Most-Cited Works
- → PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer(2019)679 cited
- → Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma(2021)602 cited
- → Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages(2017)543 cited
- → Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma(2020)345 cited
- → Macrophages: The Road Less Traveled, Changing Anticancer Therapy(2018)293 cited
- → Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer(2020)246 cited
- → Macrophages(2018)237 cited
- → The Prognostic Role of Macrophage Polarization in the Colorectal Cancer Microenvironment(2020)227 cited
- → Macrophage Biology and Mechanisms of Immune Suppression in Breast Cancer(2021)214 cited
- → Aging-Associated Alterations in Mammary Epithelia and Stroma Revealed by Single-Cell RNA Sequencing(2020)198 cited